BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18360850)

  • 1. "Anti-healing" versus "pro-healing".
    Seth DA
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):605-6. PubMed ID: 18360850
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. We can build it, but will they come?
    Gilchrist IC
    Catheter Cardiovasc Interv; 2011 May; 77(6):818-9. PubMed ID: 21520383
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid Evaluation of Vessel HEaling After AngiopLasty (REVEAL) trial: rationale, objectives and design.
    Tamburino C; Capodanno D; La Manna A; di Salvo M; Sanfilippo A; Prati F
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):53-8. PubMed ID: 19829136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous™ Bio-engineered R stent™: a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry.
    Klomp M; Damman P; Beijk MA; Silber S; Grisold M; Ribeiro EE; Suryapranata H; Wòjcik J; Sim KH; Tijssen JG; de Winter RJ;
    Heart Vessels; 2012 Jul; 27(4):360-9. PubMed ID: 21725668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The titanium nitride oxide coated stent.
    Kornowski R
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):288-90. PubMed ID: 20665879
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence-based management of patients undergoing PCI: stent controversies.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S39-42. PubMed ID: 20333706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year clinical outcome in an unselected patient population treated with the Genous™ endothelial progenitor cell capturing stent.
    Klomp M; Beijk MA; Tijssen JG; de Winter RJ
    Catheter Cardiovasc Interv; 2011 May; 77(6):809-17. PubMed ID: 20853436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late stent thrombosis--the "vulnerable" stent.
    Waksman R
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):54-6. PubMed ID: 17585385
    [No Abstract]   [Full Text] [Related]  

  • 11. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry.
    Aoki J; Serruys PW; van Beusekom H; Ong AT; McFadden EP; Sianos G; van der Giessen WJ; Regar E; de Feyter PJ; Davis HR; Rowland S; Kutryk MJ
    J Am Coll Cardiol; 2005 May; 45(10):1574-9. PubMed ID: 15893169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stent thrombosis.
    Stähli BE; Camici GG; Tanner FC
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent very late drug-eluting stent thrombosis.
    Pesarini G; Arieti M; Spadaro R; Vassanelli C; Ribichini F
    Cardiovasc Revasc Med; 2009; 10(2):130-5. PubMed ID: 19327678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel use in diabetic patients with new stents.
    Cardiovasc J Afr; 2008; 19(4):232. PubMed ID: 18776976
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug eluting stents in AMI: keep the data coming.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2008 May; 71(6):770-1. PubMed ID: 18412075
    [No Abstract]   [Full Text] [Related]  

  • 17. Paclitaxel-eluting balloon: from bench to bed.
    De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stent in saphenous vein graft lesions.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
    [No Abstract]   [Full Text] [Related]  

  • 19. Long term safety: not only a drug eluting stents issue.
    Fineschi M; Zacà V; Gori T
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):1051; author reply 1052. PubMed ID: 18044789
    [No Abstract]   [Full Text] [Related]  

  • 20. SES for AMI: moving in the right direction.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):333-4. PubMed ID: 19642181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.